Loading insider details...
Beta
Latest Form 4 (Oct 9, 2025): Sale of 308,643 INBX shares, $9.95M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 9, 2025 | Inhibrx Biosciences, Inc. (INBX) | Sale | 308,643 | $9.95M |
| Jul 1, 2025 | BridgeBio Pharma, Inc. (BBIO) | Sale | 3,500,000 | $154.00M |
| Feb 1, 2025 | BridgeBio Pharma, Inc. (BBIO) | Sale | 3,065,616 | $106.99M |
| Jun 18, 2024 | APi Group Corp (APG) | Sale | 1,912,750 | $72.97M |
| Jun 18, 2024 | APi Group Corp (APG) | Sale | 1,912,750 | $72.97M |
| Jun 3, 2024 | Inhibrx, Inc. (INBX) | Other (see footnotes) | 6,305,866 | $189.18M |
| Mar 7, 2024 | APi Group Corp (APG) | Sale | 2,977,845 | $101.99M |
| Mar 7, 2024 | APi Group Corp (APG) | Sale | 2,977,845 | $101.99M |
| Mar 1, 2024 | APi Group Corp (APG) | Conversion | 8,036,862 | $197.71M |
| Mar 1, 2024 | APi Group Corp (APG) | Conversion | 8,036,862 | $197.71M |